IAM Iambic Therapeutics, Inc.
$16.01▼ -2.02%
Healthcare
Other
Volume 978.9K
Avg Volume (10D) 2.45M
Key Metrics & Fundamentals
Market Cap
$758.89M
P/E Ratio
–
Div Yield
0.00%
52W Range
14.10 - 25.00
% vs 50 MA
–%
% vs 200 MA
–%
RSI-14
–
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Iambic Therapeutics (IAM) Filed An IND For IAM217
Simply Wall St. · Oct 18, 2026 1:15 AM ET
Iambic Therapeutics (IAM) Joins The Nasdaq Composite, Is The Stock Already Pricey?
Simply Wall St. · Oct 17, 2026 8:16 PM ET
Another Biotech IPO Pops on Rough Day for Broader Market
Barrons.com · Oct 16, 2026 1:46 PM ET
Cathie Wood-Backed Biotech IPO Pops in Debut
Barrons.com · Oct 15, 2026 1:38 PM ET
Iambic Announces Pricing of Initial Public Offering
Business Wire · Oct 14, 2026 6:52 PM ET
Toogood Gold Narrows Table Mountain Targets as Two Major Gold Corridors Take Shape
Insider Monkey · Sep 28, 2026 11:33 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
No Reddit posts found for IAM.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.